International Journal of Oral Biology

The Korean Academy of Oral Biology (대한구강생물학회)
권호 표지
DOI QR코드

DOI QR Code

Hypoxia Inducible Factor-$1{\alpha}$ Directly Induces the Expression of Receptor Activator of Nuclear Factor-${\kappa}B$ Ligand in MLO-Y4 Osteocytes

  • Baek, Kyunghwa (Department of Pharmacology, College of Dentistry and Research Institute of Oral Science, Gangneung-Wonju National University) ;
  • Park, Hyun-Jung (Department of Molecular Genetics, School of Dentistry and Dental Research Institute, Seoul National University) ;
  • Baek, Jeong-Hwa (Department of Molecular Genetics, School of Dentistry and Dental Research Institute, Seoul National University)
  • Received : 2015.02.03
  • Accepted : 2015.03.09
  • Published : 2015.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Osteocytes may function as mechanotransducers by regulating local osteoclastogenesis. Reduced availability of oxygen, i.e. hypoxia, could occur during disuse, bone development, and fracture. Receptor activator of nuclear factor-${\kappa}B$ ligand (RANKL) is an osteoblast/stromal cell derived essential factor for osteoclastogenesis. The hypoxia induced osteoclastogenesis via increased RANKL expression in osteoblasts was demonstrated. Hypoxic regulation of gene expression generally involves activation of the hypoxia-inducible factor (HIF) transcription pathway. In the present study, we investigated whether hypoxia regulates RANKL expression in murine osteocytes and HIF-$1{\alpha}$ mediates hypoxia-induced RANKL expression by transactivating RANKL promoter, to elucidate the role of osteocyte in osteoclastogenesis in the context of hypoxic condition. The expression levels of RANKL mRNA and protein, as well as hypoxia inducible factor-$1{\alpha}$ (HIF-$1{\alpha}$) protein, were significantly increased in hypoxic condition in MLO-Y4s. Constitutively active HIF-$1{\alpha}$ alone significantly increased the levels of RANKL expression in MLO-Y4s under normoxic conditions, whereas dominant negative HIF-$1{\alpha}$ blocked hypoxia-induced RANKL expression. To further explore to find if HIF-$1{\alpha}$ directly regulates RANKL transcription, a luciferase reporter assay was conducted. Hypoxia significantly increased RANKL promoter activity, whereas mutations of putative HIF-$1{\alpha}$ binding elements in RANKL promoter prevented this hypoxia-induced RANKL promoter activity in MLO-Y4s. These results suggest that HIF-$1{\alpha}$ mediates hypoxia-induced up-regulation of RANKL expression, and that in osteocytes of mechanically unloaded bone, hypoxia enhances osteoclastogenesis, at least in part, via an increased RANKL expression in osteocytes.

Keywords

References

  1. Wada T, Nakashima T, Hiroshi N, Penninger JM. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med. 2006;12:17-25. doi: 10.1016/j.molmed.2005.11.007.
  2. Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand. Bone. 1999;25:517-523. https://doi.org/10.1016/S8756-3282(99)00210-0
  3. You L, Temiyasathit S, Lee P, Kim CH, Tummala P, Yao W, Kingery W, Malone AM, Kwon RY, Jacobs CR. Osteocytes as mechanosensors in the inhibition of bone resorption due to mechanical loading. Bone. 2008;42:172-179. doi: 10.1016/j.bone.2007.09.047.
  4. Schipani E. Hypoxia and HIF-1${\alpha}$ in chondrogenesis. Ann N Y Acad Sci. 2006;1068:66-73. doi: 10.1196/annals.1346.009.
  5. Dodd JS, Raleigh JA, Gross TS. Osteocyte hypoxia: a novel mechanotransduction pathway. Am J Physiol. 1999;277: C598-602. https://doi.org/10.1152/ajpcell.1999.277.3.C598
  6. Epari DR, Lienau J, Schell H, Witt F, Duda GN. Pressure, oxygen tension and temperature in the periosteal callus during bone healing-an in vivo study in sheep. Bone. 2008;43:734-739. doi: 10.1016/j.bone.2008.06.007.
  7. Komatsu DE, Hadjiargyrou M. Activation of the transcription factor HIF-1 and its target genes, VEGF, HO-1, iNOS, during fracture repair. Bone. 2004;34:680-688. doi:10.1016/j.bone.2003.12.024.
  8. Brighton CT, Krebs AG. Oxygen tension of healing fractures in the rabbit. J Bone Joint Surg Am. 1972;54:323-332. https://doi.org/10.2106/00004623-197254020-00010
  9. Knowles HJ, Cleton-Jansen AM, Korsching E, Athanasou NA. Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4. FASEB J. 2010;24:4648-4659. doi: 10.1371/journal.pone.0085808.
  10. Park HJ, Baek KH, Lee HL, Kwon A, Hwang HR, Qadir AS, Woo KM, Ryoo HM, Baek JH. Hypoxia inducible factor-1${\alpha}$ directly induces the expression of receptor activator of nuclear factor-${\kappa}B$ ligand in periodontal ligament fibroblasts. Mol Cells. 2011;31:573-578. doi: 10.1007/s10059-010-0067-2.
  11. Riddle RC, Leslie JM, Gross TS, Clemens TL. Hypoxia-inducible factor-1${\alpha}$ protein negatively regulates load-induced bone formation. J Biol Chem. 2011;286: 44449-44456. https://doi.org/10.1074/jbc.M111.276683
  12. Loboda A, Jozkowicz A, Dulak J. HIF-1 and HIF-2 transcription factors-similar but not identical. Mol Cells. 2010;29:435-442. doi: 10.1002/jcp.10321.
  13. Stachurska A, Florczyk U, Jozkowicz A, Dulak J, Loboda A. The new face of factors induced by hypoxia-HIF-1 and HIF-2 and oxidative stress. Postepy biochemii. 2010;56:156-164. doi: 10.1002/path.2534.
  14. Arnett TR, Gibbons DC, Utting JC, Orriss IR, Hoebertz A, Rosendaal M, Meghji S. Hypoxia is a major stimulator of osteoclast formation and bone resorption. J Cell Physiol. 2003;196:2-8. doi: 10.1007/s10059-011-1055-x.
  15. Knowles HJ, Athanasou NA. Acute hypoxia and osteoclast activity: a balance between enhanced resorption and increased apoptosis. J Pathol. 2009;218:256-264. https://doi.org/10.1002/path.2534
  16. Steinbach JP, Klumpp A, Wolburg H, Weller M. Inhibition of epidermal growth factor receptor signaling protects human malignant glioma cells from hypoxia-induced cell death. Cancer research. 2004;64:1575-1578. doi: 10.1016/j.neulet.2004.12.080.
  17. Hamrick SE, McQuillen PS, Jiang X, Mu D, Madan A, Ferriero DM. A role for hypoxia-inducible factor-1${\alpha}$ in desferoxamine neuroprotection. Neurosci Lett. 2005;379: 96-100. https://doi.org/10.1016/j.neulet.2004.12.080
  18. Chun YS, Kim MS, Park JW. Oxygen-dependent and -independent regulation of HIF-1${\alpha}$. J Korean Med Sci. 2002;17:581-588. https://doi.org/10.3346/jkms.2002.17.5.581
  19. Chun YS, Choi E, Kim TY, Kim MS, Park JW. A dominant-negative isoform lacking exons 11 and 12 of the human hypoxia-inducible factor-1${\alpha}$ gene. Biochem J. 2002;362:71-79. doi: 10.1242/dev.008441.
  20. Amarilio R, Viukov SV, Sharir A, Eshkar-Oren I, Johnson RS, Zelzer E. HIF1${\alpha}$ regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis. Development. 2007;134: 3917-3928. https://doi.org/10.1242/dev.008441
  21. Semenza GL. Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochem Pharmacol. 2000;59:47-53. doi: 10.1073/pnas.0708474105.
  22. Wan C, Gilbert SR, Wang Y, Cao X, Shen X, Ramaswamy G, Jacobsen KA, Alaql ZS, Eberhardt AW, Gerstenfeld LC, Einhorn TA, Deng L, Clemens TL. Activation of the hypoxia-inducible factor-1${\alpha}$ pathway accelerates bone regeneration. Proc Natl Acad Sci U S A. 2008;105:686-691. doi: 10.1006/geno.1996.0311.
  23. Semenza GL, Rue EA, Iyer NV, Pang MG, Kearns WG. Assignment of the hypoxia-inducible factor-1${\alpha}$ gene to a region of conserved synteny on mouse chromosome 12 and human chromosome 14q. Genomics 1996;34:437-439. https://doi.org/10.1006/geno.1996.0311